HK2 and hepatocellular carcinoma: This is, in fact, true for miR-125b, which targets HK2, or miR-34a, which is lactate dehydrogenase (LDHA), an essential enzyme in glycolysis, thereby restraining glycolysis in HCC cells [177,178].